339 related articles for article (PubMed ID: 814800)
1. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
2. The hallucinogens and the inhalants.
Cohen S
Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of hallucinogenic drugs on behavior of the cat.
Jacobs BL; Trulson ME; Stark AD; Christoph GR
Commun Psychopharmacol; 1977; 1(3):243-54. PubMed ID: 272265
[No Abstract] [Full Text] [Related]
4. Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents.
Glennon RA; Rosecrans JA; Young R
Med Res Rev; 1983; 3(3):289-340. PubMed ID: 6350763
[No Abstract] [Full Text] [Related]
5. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
6. A comparison of the phenomenology of hallucinogens and schizophrenia from some autobiographical accounts.
Kleinman JE; Gillin JC; Wyatt RJ
Schizophr Bull; 1977; 3(4):560-86. PubMed ID: 271353
[No Abstract] [Full Text] [Related]
7. Neurotransmitter basis of the behavioral effects of hallucinogens.
Rech RH; Commissaris RL
Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
[TBL] [Abstract][Full Text] [Related]
8. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
9. The lack of correlation between hallucinogenesis and inhibition of axoplasmic transport.
Paulson JC; McClure WO
Mol Pharmacol; 1974 May; 10(3):419-24. PubMed ID: 4137280
[No Abstract] [Full Text] [Related]
10. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
Trulson ME; Heym J; Jacobs BL
Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological action spectra of hallucinogens].
Waser PG
Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
[No Abstract] [Full Text] [Related]
12. [Drug dependence. A review of the narcotic and hallucinogenic effects of drugs].
Haan J
Med Monatsschr Pharm; 1981 May; 4(5):129-37. PubMed ID: 7024769
[No Abstract] [Full Text] [Related]
13. Some aspects of the current drug scene with emphasis on drugs in use by adolescents.
Louria DB
Pediatrics; 1968 Dec; 42(6):904-11. PubMed ID: 5726384
[No Abstract] [Full Text] [Related]
14. The pharmacology of hallucinogens.
Brawley P; Duffield JC
Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
[No Abstract] [Full Text] [Related]
15. [Narcotics abuse in adolescents].
Leuner H
Nervenarzt; 1971 Jun; 42(6):281-91. PubMed ID: 4931883
[No Abstract] [Full Text] [Related]
16. Psilocybin as a discriminative stimulus: lack of specificity in an animal behavior model for 'hallucinogens'.
Koerner J; Appel JB
Psychopharmacology (Berl); 1982; 76(2):130-5. PubMed ID: 6805022
[TBL] [Abstract][Full Text] [Related]
17. 2,5-dimethoxy-4-methyl-amphetamine (STP): a new hallucinogenic drug.
Snyder SH; Faillace L; Hollister L
Science; 1967 Nov; 158(3801):669-70. PubMed ID: 4860952
[TBL] [Abstract][Full Text] [Related]
18. A characteristic effect of hallucinogens on investigatory responding in rats.
Geyer MA; Light RK; Rose GJ; Petersen LR; Horwitt DD; Adams LM; Hawkins RL
Psychopharmacology (Berl); 1979 Sep; 65(1):35-40. PubMed ID: 116288
[TBL] [Abstract][Full Text] [Related]
19. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
Pierce PA; Peroutka SJ
Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505
[TBL] [Abstract][Full Text] [Related]
20. Interactions of hallucinogens at the clinical level.
Wyatt RJ; Cannon EH; Stoff DM; Gillin JC
Ann N Y Acad Sci; 1976; 281():456-86. PubMed ID: 828469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
